World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 October 2016
Main ID:  NCT02912832
Date of registration: 09/09/2016
Prospective Registration: No
Primary sponsor: Foundation for Innovative New Diagnostics, Switzerland
Public title: Prospective Assessment of TBDx Feasibility
Scientific title: TBDx Feasibility Study: Prospective Study to Determine the Feasibility of Automated Smear Microscopy
Date of first enrolment: October 2014
Target sample size: 572
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02912832
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Diagnostic  
Phase:  N/A
Countries of recruitment
Peru Vietnam
Contacts
Name:     Claudia M Denkinger, MD
Address: 
Telephone:
Email:
Affiliation:  FIND
Key inclusion & exclusion criteria

Inclusion Criteria:

- Persistent cough (>2 weeks) and at least one other typical symptom of pulmonary TB
(fever, night sweats, malaise, recent weight loss, contact with active case,
hemoptysis, chest pain, loss of appetite)

- Provision of informed consent (FIND TB Reference Materials)

- Provision of sputum for adequate testing

Exclusion Criteria:

- Patients receiving any anti-TB medication, in the 60 days prior to testing.

- Patients with only extra-pulmonary disease



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Pulmonary Tuberculosis
Intervention(s)
Device: TBDx
Primary Outcome(s)
Performance of TBDx compared to culture [Time Frame: 6 months]
Secondary Outcome(s)
Performance of TBDx in combination with Xpert MTB/RIF through analysis of two different algorithms [Time Frame: 6 months]
Training needs through questionnaire assessment [Time Frame: 6 months]
User appraisal regarding ease of use, hands-on-time and perceived benefit through appraisal questionnaire [Time Frame: 6 months]
Comparison of performance of TBDx on direct vs concentrated smear [Time Frame: 6 months]
Identify potential difficulties for implementation through observation and user appraisal [Time Frame: 6 months]
Secondary ID(s)
7012-05-3/1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history